Global and gene‐specific analyses show distinct roles for Myod and Myog at a common set of promoters

We used a combination of genome‐wide and promoter‐specific DNA binding and expression analyses to assess the functional roles of Myod and Myog in regulating the program of skeletal muscle gene expression. Our findings indicate that Myod and Myog have distinct regulatory roles at a similar set of target genes. At genes expressed throughout the program of myogenic differentiation, Myod can bind and recruit histone acetyltransferases. At early targets, Myod is sufficient for near full expression, whereas, at late expressed genes, Myod initiates regional histone modification but is not sufficient for gene expression. At these late genes, Myog does not bind efficiently without Myod; however, transcriptional activation requires the combined activity of Myod and Myog. Therefore, the role of Myog in mediating terminal differentiation is, in part, to enhance expression of a subset of genes previously initiated by Myod.

[1]  Qing Xu,et al.  p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. , 2002, Molecular biology of the cell.

[2]  S. Tapscott,et al.  Amplification of MDM2 inhibits MyoD-mediated myogenesis , 1996, Molecular and cellular biology.

[3]  A. Kawasaki,et al.  Reciprocal Inhibition between MyoD and STAT3 in the Regulation of Growth and Differentiation of Myoblasts* , 2003, Journal of Biological Chemistry.

[4]  Nicola J. Rinaldi,et al.  Control of Pancreas and Liver Gene Expression by HNF Transcription Factors , 2004, Science.

[5]  D. Lockshon,et al.  MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Olson,et al.  Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Olson,et al.  The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Buckingham,et al.  The formation of skeletal muscle: from somite to limb , 2003, Journal of anatomy.

[9]  Ling Lin,et al.  Highly Coordinated Gene Regulation in Mouse Skeletal Muscle Regeneration* 210 , 2003, The Journal of Biological Chemistry.

[10]  Nicola J. Rinaldi,et al.  Transcriptional regulatory code of a eukaryotic genome , 2004, Nature.

[11]  S. Tapscott,et al.  A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. , 2004, Genes & development.

[12]  M. Rudnicki,et al.  MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.

[13]  S. Tapscott,et al.  Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. , 2004, Molecular cell.

[14]  L. Kedes,et al.  Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection , 1996, Molecular and cellular biology.

[15]  P. Goldschmidt-Clermont,et al.  Transforming Growth Factor-&bgr;–Induced Inhibition of Myogenesis Is Mediated Through Smad Pathway and Is Modulated by Microtubule Dynamic Stability , 2004, Circulation research.

[16]  H. Weintraub,et al.  Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Pavlath,et al.  Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. , 2003, Differentiation; research in biological diversity.

[18]  S. Tapscott,et al.  A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. , 1999, Nucleic acids research.

[19]  C. Simone,et al.  p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci , 2004, Nature Genetics.

[20]  S. Rhodes,et al.  Differential trans activation associated with the muscle regulatory factors MyoD1, myogenin, and MRF4 , 1990, Molecular and cellular biology.

[21]  Yizheng Li,et al.  Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. , 2002, Physiological genomics.

[22]  Bin Wang,et al.  Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation , 2004, Development.

[23]  C. Emerson,et al.  Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. , 2002, Annual review of cell and developmental biology.

[24]  Richard A Young,et al.  Global and Hox-specific roles for the MLL1 methyltransferase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Barbara Gayraud-Morel,et al.  Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice , 2004, Nature.

[26]  R. Sharan,et al.  An initial blueprint for myogenic differentiation. , 2005, Genes & development.

[27]  M. Rudnicki,et al.  Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. , 2002, Molecular cell.

[28]  William H. Klein,et al.  Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene , 1993, Nature.

[29]  Voichita D. Marinescu,et al.  Expression profiling and identification of novel genes involved in myogenic differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  S. Tapscott,et al.  MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. , 1988, Science.

[31]  H. Weintraub,et al.  Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. , 1990, Science.

[32]  Nicola J. Rinaldi,et al.  Transcriptional Regulatory Networks in Saccharomyces cerevisiae , 2002, Science.

[33]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[34]  R. Jaenisch,et al.  Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. , 1997, Development.

[35]  R. Humphries,et al.  Functional Cloning and Characterization of a Novel Nonhomeodomain Protein That Inhibits the Binding of PBX1-HOX Complexes to DNA* , 2000, The Journal of Biological Chemistry.

[36]  E. Olson,et al.  Calcineurin Signaling and Muscle Remodeling , 2000, Cell.

[37]  A. Asakura,et al.  MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors , 1993, Molecular and cellular biology.

[38]  S. Tapscott,et al.  MyoD Targets Chromatin Remodeling Complexes to the Myogenin Locus Prior to Forming a Stable DNA-Bound Complex , 2005, Molecular and Cellular Biology.

[39]  J. Schmidt,et al.  Interaction of MyoD Family Proteins with Enhancers of Acetylcholine Receptor Subunit Genes in Vivo * , 2000, The Journal of Biological Chemistry.

[40]  Pumin Zhang,et al.  Dynamic gene expression during the onset of myoblast differentiation in vitro. , 2003, Genomics.

[41]  E. Olson,et al.  Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  I. Nonaka,et al.  Myogenin gene disruption results in perinatal lethality because of severe muscle defect , 1993, Nature.

[43]  J. Johnson,et al.  The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer , 1988, Molecular and cellular biology.

[44]  S. Tapscott,et al.  Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. , 1997, Genes & development.

[45]  J. Collier,et al.  Genome‐wide examination of myoblast cell cycle withdrawal during differentiation , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[46]  L. Kedes,et al.  Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.

[47]  D. Yaffe,et al.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle , 1977, Nature.

[48]  R. Gascoyne,et al.  Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  S. Tapscott,et al.  Muscle-specific transcriptional activation by MyoD. , 1991, Genes & development.

[50]  M. Rudnicki,et al.  The molecular regulation of myogenesis , 2000, Clinical genetics.

[51]  H. Weintraub,et al.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation , 1990, Cell.

[52]  S. Tapscott,et al.  Molecular Distinction between Specification and Differentiation in the Myogenic Basic Helix-Loop-Helix Transcription Factor Family , 2001, Molecular and Cellular Biology.